Catalog Number 631500 |
Device Problem
Chemical Problem (2893)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/25/2023 |
Event Type
malfunction
|
Event Description
|
It was reported, via a personal interaction, that a trufill n-bca-1 gram kit (631500/lot # unknown) was used for an arteriovenous malformation (avm) embolization procedure on a 16-year-old male patient, during which the user reported ¿trufill mixed at 4:1 ratio with some tantalum powder¿ polymerized too fast in the microcatheter.The user reported to have flushed the balt magic microcatheter with dextrose 5% solution, and inject the trufill n-bca liquid embolic agent, which then ¿almost immediately clogged completely inside the microcatheter lumen¿.The event was said to have delayed the surgical procedure by 10 minutes.A new microcatheter and a new trufill n-bca-1 gram kit had to be used instead to complete the procedure.The treating physician further commented that ¿if he had used onyx the procedure would have already been finished without delay¿.The event did not result in patient injury, death, additional intervention to preclude serious injury or death, hospitalization, prolongation of existing hospitalization, or permanent disability.The procedure was successfully completed.No fragments were generated.No further information was made available at the time of this review.
|
|
Manufacturer Narrative
|
Product complaint (b)(4).Information regarding patient weight, height, medical history, race, and ethnicity was not reported.Section d3 ¿ the product lot number was not reported.Section h3 - the device is available to be returned for evaluation and testing.However, it has not been received to date as indicated as ¿other¿ in this section as the reason for non-evaluation.If the device returns, a device investigation will be performed.Missing information from this report is identified as blank; this information was not provided in the reported event or available at the time of report submission.The company is seeking this information through the event investigation.This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).The product has been returned for evaluation and testing; however, the engineering evaluation has not been completed.A supplemental report will be submitted if new facts arise which materially alter information submitted in a previous mdr report.
|
|
Search Alerts/Recalls
|
|